Scarica l'app Stockscreener
89.24
1.02%
0.90
Pre-mercato:
89.15
-0.09
-0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$88.34
Aprire:
$87.86
Volume 24 ore:
3.98M
Relative Volume:
1.91
Capitalizzazione di mercato:
$17.69B
Reddito:
$7.83B
Utile/perdita netta:
$825.20M
Rapporto P/E:
21.73
EPS:
4.1067
Flusso di cassa netto:
$1.05B
1 W Prestazione:
-3.70%
1M Prestazione:
-2.57%
6M Prestazione:
-4.92%
1 anno Prestazione:
-14.77%
Intervallo 1D:
$85.76
$89.75
Intervallo di 1 settimana:
$85.76
$94.94
Portata 52W:
$85.33
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
89.24 | 17.51B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
125.00 | 216.14B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
93.74 | 139.56B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
359.39 | 136.07B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.74 | 123.61B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.10 | 48.65B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet Announces Q4 2026 Earnings Call Date - Intellectia AI
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results - Financial Times
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US - Yahoo Finance
Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)? - Yahoo Finance
JPM26: Zimmer Biomet reveals plans for largest patient campaign in its history - Yahoo Finance
Zimmer Biomet (ZBH) Cautions Investors Ahead of Earnings Release - GuruFocus
Zimmer Biomet down after cautious remarks on outlook (ZBH:NYSE) - Seeking Alpha
Setup Watch: Can Zimmer Biomet Holdings Inc stock outperform in 2025 bull marketEarnings Trend Report & AI Enhanced Trading Signals - moha.gov.vn
Zimmer Biomet (ZBH) Ensures Cautious Outlook for 2026 Transforma - GuruFocus
Zimmer Biomet’s Q3 2025 Earnings: What to Expect - Yahoo Finance
Zimmer Biomet Holdings Inc (NYSE:ZBH) Screened as a 'Decent Value' Investment Opportunity - Chartmill
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Nisa Investment Advisors LLC - MarketBeat
Dip Buying: Will Zimmer Biomet Holdings Inc outperform its industry peersPortfolio Performance Report & Comprehensive Market Scan Insights - baoquankhu1.vn
Published on: 2026-01-13 03:09:07 - Улправда
Zimmer Biomet Holdings Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Zimmer Biomet Holdings (ZBH) Announces Executive Resignation - GuruFocus
Zimmer Biomet Holdings (ZBH): Growth Potential in the Medical Device Sector Amidst Analyst Consensus - DirectorsTalk Interviews
The Truth About Zimmer Biomet: Is This ‘Boring’ Stock Your Next Silent Money Machine? - AD HOC NEWS
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by SG Americas Securities LLC - MarketBeat
Nasdaq Moves: What earnings margins imply for Zimmer Biomet Holdings Inc. (ZIM) stockJuly 2025 News Drivers & Community Consensus Stock Picks - ulpravda.ru
RBC Capital Keeps Their Buy Rating on Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Zimmer Biomet (ZBH): Bernstein Raises Price Target Amid Stable R - GuruFocus
Bernstein Adjusts Price Target on Zimmer Biomet to $99 From $97, Maintains Market Perform Rating - marketscreener.com
HOKA Size Guide: What earnings margins imply for Zimmer Biomet Holdings Inc. (ZIM) stockLong Run Comfort Guide & stability guidance for smoother miles - ulpravda.ru
Zimmer Biomet Holdings, Inc. $ZBH is Oak Family Advisors LLC's 10th Largest Position - MarketBeat
Goldman Sachs Downgrades Zimmer Biomet to Sell From Neutral, Adjusts Price Target to $93 From $97 - marketscreener.com
Zimmer Biomet (ZBH) Valuation Check After Fresh Evercore Upgrade To Outperform - Yahoo Finance
Why Zimmer Biomet Holdings Inc. stock could benefit from AI revolutionQuarterly Trade Review & Precise Entry and Exit Recommendations - ulpravda.ru
What risks investors should watch in Zimmer Biomet Holdings Inc. stockJuly 2025 Recap & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Zimmer Biomet Holdings Inc. (ZIM) stock appeals to dividend investorsCEO Change & Precise Buy Zone Tips - ulpravda.ru
BTIG Research Reiterates "Buy" Rating for Zimmer Biomet (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings (ZBH) Rating Reiterated at 'Buy' by BTIG - GuruFocus
Zimmer Biomet inks a partnership with PatientIQ - MassDevice
Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pickMarket Rumors and News & High Profit Market Ideas - ulpravda.ru
Published on: 2026-01-07 19:33:36 - ulpravda.ru
Sivik Global Healthcare LLC Buys New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Absher Wealth Management LLC Invests $2.34 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (XSWX:ZBH) EV-to-OCF : 14.18 (As of Jan. 06, 2026) - GuruFocus
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet stock: Is ZBH underperforming the health care sector? - MSN
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Raymond James Downgrades Zimmer Biomet to Market Perform From Outperform - marketscreener.com
Zimmer Biomet (ZBH) director Louis Shapiro gains phantom stock units - Stock Titan
Zimmer Biomet (ZBH) director reports 304 new phantom stock units - Stock Titan
[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity - Stock Titan
Zimmer Biomet (NYSE: ZBH) director adds phantom stock units under deferred plan - Stock Titan
Zimmer Biomet (ZBH) director discloses new phantom stock units in Form 4 - Stock Titan
Zimmer Biomet (ZBH) director reports 304 new phantom stock units, total 31,586 - Stock Titan
Zimmer Biomet (ZBH) director adds phantom stock units in deferred plan - Stock Titan
Evercore ISI Group Upgrades Zimmer Biomet Holdings (ZBH) Rating - GuruFocus
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring A 13.35% Upside Potential - DirectorsTalk Interviews
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.70%
0.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):